Issue · Healthcare

Healthcare (Substance Abuse)

Every healthcare bill, vote, and legislator stance in New Jersey, automatically classified by Maddy, our AI policy reader.

Total bills
154
2026-2027 Regular Session
Top supporter
-
no data yet
Top opponent
-
no data yet
Ranked legislators
0
0 support · 0 oppose
Showing 11–20 of 154 bills

All healthcare bills

in committee · New Jersey · General Assembly Jun 15, 2026

A 5185: Revises regulation of certain health care facilities.

This bill updates regulations for health care facilities in New Jersey, specifically targeting narcotic and substance use disorder treatment centers. It increases the daily fines for operating these centers without approval or after a license is revoked, raising penalties from $25 to $12,500 for a first offense and from $50 to $25,000 for subsequent offenses. The legislation also grants the state commissioner expanded powers to conduct inspections, require detailed financial and quality reports, and appoint monitors for hospitals facing financial distress. Additionally, the bill allows owners and immediate family members to reside on the third floor of private long-term care facilities, overriding previous safety code restrictions.
in committee · New Jersey · Senate May 18, 2026

S 4299: Provides funding for Division of State Police opioid-related initiatives; appropriates up to $5 million annually.

This bill establishes a dedicated fund to manage money received from national opioid litigation settlements and appropriates up to $5 million annually for related state police initiatives. It designates the Department of Human Services as the lead agency responsible for distributing these funds to counties and municipalities while ensuring compliance with settlement terms. The legislation also creates a mechanism for the fund to earn interest and allows the department to adopt temporary regulations to oversee the allocation and reporting of these resources.
in committee · New Jersey · Senate May 4, 2026

S 4087: Requires DHS to establish system to ensure distribution of funds for certain support services for General Assistance beneficiaries ceases upon beneficiary's exit from support service.

This New Jersey bill requires the Department of Human Services to create a system that stops funding for substance use disorder treatment and housing once a General Assistance recipient leaves the service. The law authorizes officials to contact providers and beneficiaries to verify when services ended and to demand repayment from any provider who received funds for a client who is no longer receiving care. By mandating immediate cessation of payments upon discharge, the measure aims to prevent the state from paying for services that are no longer being delivered.
Sub-Topics Substance Abuse
in committee · New Jersey · Senate Mar 19, 2026

S 4025: Provides for independent prescriptive authority for midwives.

This bill would grant certified midwives in New Jersey independent authority to prescribe certain drugs, removing the current requirement that they must work under standing orders or practice protocols developed with a collaborating physician. To qualify for this new prescribing power, midwives must complete 30 hours of pharmacology training, including one hour focused on prescription opioid safety and responsible prescribing practices. The State Board of Medical Examiners would oversee the licensing process and has authority to prohibit prescribing privileges if a midwife violates relevant laws or regulations. This change expands midwives' clinical autonomy while maintaining educational standards and oversight mechanisms.
Sub-Topics Substance Abuse
in committee · New Jersey · Senate Mar 5, 2026

S 3765: Requires DHS to request approval from federal government to provide rental assistance benefits to certain NJ FamilyCare beneficiaries.

This bill directs New Jersey's Department of Human Services to seek federal approval to offer rental assistance to specific NJ FamilyCare beneficiaries for up to six months. The program would target individuals who are homeless, at risk of homelessness, or transitioning out of emergency shelters and who have been diagnosed with a serious mental illness or substance use disorder. If approved, the state would issue financial assistance vouchers or subsidies directly to housing providers to help eligible recipients secure or maintain housing. The bill also requires the state to adopt new rules and regulations to implement the program once federal permission is granted.
in committee · New Jersey · Senate Mar 19, 2026

S 4027: Clarifies DHS authority to regulate sober living homes and halfway houses as residential substance abuse aftercare facilities; requires background checks and other protections for residents of residential substance abuse facilities.

This bill clarifies the New Jersey Department of Human Services' authority to regulate sober living homes and halfway houses as residential substance abuse aftercare facilities. It requires background checks and other safety protections for residents of these facilities to ensure safer living environments for individuals recovering from substance use disorders. The legislation also mandates that the department maintain and publish a public list of all regulated facilities and notify law enforcement agencies of their locations and capacities. By updating existing state laws, the bill aims to standardize oversight and improve accountability for residential treatment facilities across the state.
in committee · New Jersey · General Assembly Mar 23, 2026

A 4798: Establishes Office of Alcohol and Drug Use Disorders Policy to oversee, direct, and coordinate resources, funding, and data tracking concerning treatment of substance use disorders.

This bill creates a new Office of Alcohol and Drug Use Disorders Policy within the New Jersey Executive Branch to coordinate statewide efforts related to substance use disorder treatment and prevention. The office will report directly to the Governor and is responsible for reviewing and unifying programs across state, county, and local agencies, while also managing grant distributions to counties and municipalities. Key provisions include the requirement to submit an annual comprehensive master plan, evaluate existing funding mechanisms, collect data for tracking, and convene regular meetings with various state commissioners to improve service coordination. The office will have the authority to request information and resources from any state department to fulfill its duties.
Sub-Topics Substance Abuse
in committee · New Jersey · Senate Mar 12, 2026

S 3904: Prohibits procurement of opioid antidotes from certain entities.

This bill prohibits New Jersey state agencies from purchasing opioid antidotes, such as naloxone, from pharmaceutical companies that have settled legal claims with the state over their role in the opioid epidemic. It requires that procurement requests for these medications be sent only to manufacturers and distributors that have not been part of such settlements, including their affiliates and subsidiaries. The law allows companies that agreed to supply antidotes as part of a settlement entered into before September 1, 2024, to continue providing them until their existing obligations are met. State agencies must also use available federal funding to purchase these medications only from vendors that meet the settlement-free criteria.
in committee · New Jersey · Senate Mar 19, 2026

S 4030: Designates minimum percentage of residential substance use disorder treatment facility beds for use by NJ FamilyCare eligible individuals as condition for licensure.

This bill requires all new and existing residential substance use disorder treatment facilities in New Jersey to reserve at least 40 percent of their beds for individuals eligible for NJ FamilyCare, the state's Medicaid program. Facilities must meet this requirement within 12 months of initial licensure or license renewal and maintain it going forward. The Department of Health will not issue or renew licenses for facilities that fail to comply with this bed allocation mandate. The law applies to various types of residential treatment settings, including halfway houses, extended care facilities, and detoxification centers.
in committee · New Jersey · General Assembly Mar 16, 2026

A 4694: Requires prescription drug coverage for serious mental illness without prior authorization or utilization management, including step therapy.

This bill requires insurance carriers in New Jersey to cover prescription drugs for serious mental illnesses like schizophrenia, bipolar disorder, and PTSD without requiring prior authorization or step therapy. It directly affects individuals with these conditions who need mental health coverage through health plans, ensuring they can access necessary medications without unnecessary administrative hurdles. The law also mandates that insurers report annually on how they develop medical necessity criteria for mental health and substance use disorder treatments, increasing transparency in coverage decisions. Additionally, carriers must provide information about in-plan exceptions when qualified providers are not available in their network.
Showing 11 to 20 of 154 bills